Genetic testing is the primary method for detecting mutations in MLH1, MSH2, MSH6, and PMS2. Individuals with a family history of Lynch syndrome or related cancers are often advised to undergo genetic counseling and testing. Techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) are commonly used to identify these mutations.
